openheart.bmj5d
Sudden cardiac death after acute myocarditis with arrhythmic presentation: hunting for risk predictors − a systematic review and meta-analysis
An increased risk of adverse outcomes during follow-up was observed in patients presenting with monomorphic ventricular tachycardia (OR 3.77, 95% CI 1.23 to 11.53) and left ventricular ejection ...
openheart.bmj15d
Clinical features, myocardial injury and systolic impairment in acute myocarditis
LVEF was 58±11%. The median time from the peak troponin to ... The coefficients have been exponentiated for easier interpretation. Top troponin tertile, diabetes and male sex are all significantly ...
Frontiers19d
Interventions for prevention and treatment of trastuzumab-induced cardiotoxicity: an umbrella review of systematic reviews and meta-analyses
The methodological quality was assessed using the AMSTAR-2 tool. Data on cardiac events, treatment interruptions, left ventricular ejection fraction (LVEF) changes, and exercise interventions were ...
Renal & Urology News20d
AHA: Variation Seen in Rates of SGLT2i Rx for Heart Failure, LVEF >40 Percent
The researchers found that 13.9% of 158,849 eligible patients with heart failure and an LVEF >40% were prescribed an SGLT2i at hospital discharge. There was an increase in quarterly prescription ...
Canada26d
S-13 Royal Assent: Upholding Section 35 rights through a non-derogation clause in the federal Interpretation Act
On November 27, 2024, Bill S-13, An Act to amend the Interpretation Act and to make related amendments to other Acts, received Royal Assent and immediately came into force. This legislation adds a ...
healthday26d
AHA: Variation Seen in Rates of SGLT2i Rx for Heart Failure, LVEF >40 Percent
TUESDAY, Nov. 26, 2024 (HealthDay News) -- From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for patients with heart failure and a ...
American College of Cardiology27d
Ablation as First-Line Treatment in Tolerated VT and LVEF >35%
Post-MI patients with an LVEF >35% who presented with hemodynamically tolerated VT, and who were noninducible for any VT after ablation, had an excellent long-term outcome. Overall, these data suggest ...